Yifu He

4.1k total citations
78 papers, 717 citations indexed

About

Yifu He is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Yifu He has authored 78 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 33 papers in Oncology and 27 papers in Surgery. Recurrent topics in Yifu He's work include Gastric Cancer Management and Outcomes (23 papers), Lung Cancer Treatments and Mutations (12 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers). Yifu He is often cited by papers focused on Gastric Cancer Management and Outcomes (23 papers), Lung Cancer Treatments and Mutations (12 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers). Yifu He collaborates with scholars based in China, South Korea and Bangladesh. Yifu He's co-authors include Bing Hu, Bing Hu, Xinghua Han, Qikai Sun, Yueyin Pan, Dabing Huang, Xiaojun Qian, Wei Wang, Xiuwen Wang and Wei Wang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Yifu He

70 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yifu He China	16	283	238	191	177	131	78	717
Dedong Cao China	17	270 1.0×	396 1.7×	225 1.2×	205 1.2×	92 0.7×	50	773
Maki Tanioka Japan	17	261 0.9×	335 1.4×	166 0.9×	111 0.6×	104 0.8×	76	841
Marco Puzzoni Italy	16	213 0.8×	438 1.8×	159 0.8×	174 1.0×	68 0.5×	50	737
Yuko Sugiyama Japan	14	244 0.9×	346 1.5×	153 0.8×	127 0.7×	96 0.7×	62	968
Guanghai Dai China	15	265 0.9×	281 1.2×	223 1.2×	121 0.7×	57 0.4×	61	663
Guoan Xiang China	17	439 1.6×	192 0.8×	210 1.1×	111 0.6×	116 0.9×	50	853
Yongfu Xiong China	19	516 1.8×	254 1.1×	312 1.6×	211 1.2×	76 0.6×	56	1.0k
Sang Soo Kim South Korea	18	288 1.0×	255 1.1×	124 0.6×	283 1.6×	127 1.0×	45	845
Yuichiro Yokoyama Japan	15	348 1.2×	287 1.2×	152 0.8×	95 0.5×	99 0.8×	89	937
Jian He China	15	259 0.9×	271 1.1×	209 1.1×	341 1.9×	75 0.6×	45	828

Countries citing papers authored by Yifu He

Since Specialization

Citations

This map shows the geographic impact of Yifu He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifu He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifu He more than expected).

Fields of papers citing papers by Yifu He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yifu He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifu He. The network helps show where Yifu He may publish in the future.

Co-authorship network of co-authors of Yifu He

This figure shows the co-authorship network connecting the top 25 collaborators of Yifu He. A scholar is included among the top collaborators of Yifu He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifu He. Yifu He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Lu, Juan Li, Fang Zhang, et al.. (2025). Immunoglobulin‐like transcript 5 polarizes M2‐like tumor‐associated macrophages for immunosuppression in non‐small cell lung cancer. International Journal of Cancer. 156(11). 2225–2236. 4 indexed citations

Hu, Yuqi, et al.. (2025). Evaluation of the diagnostic efficiency of fluorescence in situ hybridization for pulmonary tuberculosis: a systematic review and meta-analysis. Frontiers in Medicine. 11. 1467530–1467530.

Su, Ying Hua, Yuqi Jiang, Yifu He, et al.. (2025). Effects of astragalus polysaccharide on the physicochemical properties of heat-induced whey protein gels by simultaneous rheology and Fourier transform infrared spectroscopy. Journal of Dairy Science. 108(5). 4626–4637. 4 indexed citations

Li, Mengge, Ying Yan, Huijun Xu, et al.. (2025). Patient-Reported Outcome-Based Symptom Management Improves Quality of Life in Postoperative Gastroesophageal Cancer Patients: A Randomized Controlled Trial. Oncology. 104(2). 201–211.

Zhou, Jing, Shoumei Yang, Xianfu Gao, et al.. (2025). Precise nutritional diagnosis in digestive system malignancies based on blood nutrients, inflammatory makers, intestinal function indicators and body composition. Clinical Nutrition. 54. 251–264.

Liang, Han, et al.. (2024). Research hotspots and trends of molecular dynamics simulations in membrane-based water treatment: A bibliometric analysis from 2003 to 2023. Separation and Purification Technology. 358. 130398–130398. 2 indexed citations

Zhang, Xiaotian, Yakun Wang, Xiaojun Xiang, et al.. (2024). Efficacy and safety of cadonilimab in combination with pulocimab and paclitaxel as second-line therapy in patients with advanced gastric or gastroesophageal junction (G/GEJ) cancer who failed immunochemotherapy: A multicenter, double-blind, randomized trial.. Journal of Clinical Oncology. 42(16_suppl). 4012–4012. 2 indexed citations

Dong, Jian, Chuan Jin, Zuoxing Niu, et al.. (2024). Iparomlimab (QL1604) in patients (pts) with unresectable/metastatic deficient mismatch repair (dMMR)/microsatellite instability high (MSI-H) solid tumors: A single-arm, multicenter, pivotal, phase II study.. Journal of Clinical Oncology. 42(16_suppl). 3578–3578. 1 indexed citations

Qiu, Miao‐Zhen, Yuxian Bai, Jufeng Wang, et al.. (2024). Addition of SHR-1701 to first-line capecitabine and oxaliplatin (XELOX) plus bevacizumab for unresectable metastatic colorectal cancer. Signal Transduction and Targeted Therapy. 9(1). 349–349. 5 indexed citations

10.

Xu, Huijun, Yang Yang, Mengge Li, et al.. (2024). Safety and Efficacy of Rechallenge With Immune Checkpoint Inhibitors in Advanced Solid Tumor: A Systematic Review and Meta‐Analysis. Cancer Medicine. 13(20). e70324–e70324. 5 indexed citations

11.

Liu, Xudong, Zhihua Zhang, Haoyu Wang, et al.. (2024). Association between quantitative CT body composition analysis and prognosis in cetuximab-based first-line treatment for advanced colorectal cancer patients. BMC Cancer. 24(1). 1579–1579. 2 indexed citations

12.

Zhang, Zhihua, et al.. (2023). Pretreatment lymphocyte-monocyte ratio (LMR) as a superior predictor of short-term progression outcomes in patients with gastric cancer receiving second- and later-line apatinib regimens. Journal of Cancer Research and Clinical Oncology. 149(12). 10715–10726. 3 indexed citations

13.

Jia, Wei, Yifu He, Xiaojun Qian, & Jian Chen. (2022). TPMT mRNA Expression: A Novel Prognostic Biomarker for Patients with Colon Cancer by Bioinformatics Analysis. SHILAP Revista de lepidopterología. 4 indexed citations

14.

Yan, Ying, Huimin Li, Gang Wang, et al.. (2022). Efficacy and safety of intermittent versus continuous dose apatinib plus docetaxel as second-line therapy in patients with advanced gastric cancer or gastroesophageal junction adenocarcinoma: a randomized controlled study. Annals of Translational Medicine. 10(4). 205–205. 5 indexed citations

15.

Luo, Huiqin, et al.. (2019). The role of prostaglandin E receptor 2 and epidermal growth factor receptor in esophageal squamous cell carcinoma patients with (pN+) regional lymph node metastasis. Translational Cancer Research. 8(4). 1233–1241. 1 indexed citations

16.

Wang, Wei, et al.. (2019). Peroxiredoxin 4 suppresses anoikis and augments growth and metastasis of hepatocellular carcinoma cells through the β-catenin/ID2 pathway. Cellular Oncology. 42(6). 769–781. 24 indexed citations

17.

Huang, Dabing, Yong Wang, Yifu He, et al.. (2018). Paraoxonase 3 is involved in the multi-drug resistance of esophageal cancer. Cancer Cell International. 18(1). 168–168. 14 indexed citations

18.

He, Yifu. (2013). A phase II study of paclitaxel and nedaplatin as front-line chemotherapy in Chinese patients with metastatic esophageal squamous cell carcinoma. World Journal of Gastroenterology. 19(35). 5910–5910. 17 indexed citations

19.

Pan, Feng, Jing Tian, Yifu He, et al.. (2012). Association of TNF-α-308 and -238 Polymorphisms with Risk of Cervical Cancer: A Meta-analysis. Asian Pacific Journal of Cancer Prevention. 13(11). 5777–5783. 24 indexed citations

20.

He, Yifu, et al.. (2007). Fatal lactic acidosis and hypoglycemia in a patient with relapsed natural killer/T-cell lymphoma. Advances in Therapy. 24(3). 505–509. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact